Brief: Targovax Granted U.S. Patent
March 9 (Reuters) - Targovax ASA TRVX.OL :
* TARGOVAX GRANTED US PATENT FOR ONCOS-102 IN COMBINATION WITH CHECKPOINT INHIBITORS
* US PATENT OFFICE HAS GRANTED US PATENT NO 10,940,203. PATENT COVERS USE OF ONCOS-102 IN
COMBINATION WITH CHECKPOINT INHIBITORS (CPI).
Source text for Eikon: ID:nWkr5kWNHx
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration